News    Sports    Entertainment
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Thursday, March 11, 2010 2:42 PM

imiquimod

Image
Type: Keyphrase
Name: imiquimod
First Reported Mar 10 2010 - Updated Mar 10 2010 - 1 Documents

Graceway Announces Journal Of The American Academy Of Dermatology Publishes Articles On New Short-Course Imiquimod Formulation In Actinic Keratosis

Graceway Announces Journal Of The American Academy Of Publishes Articles On New Short-Course Imiquimod Formulation In Actinic Keratosis Journal of the American Academy of (JAAD) has published Phase III data evaluating the safety and efficacy of imiquimod ... [Published Mar 10 2010 by MediLexicon]
First Reported Mar 09 2010 - Updated Mar 09 2010 - 2 Documents

Phase III study demonstrates superiority of imiquimod cream 2.5% and 3.75% in treatment of AK

Imiquimod 3.75% Is Now Available In Pharmacies Across CanadaThe Journal of the American Academy of Dermatology (JAAD) has published Phase III data evaluating the safety and efficacy of imiquimod cream at two doses - 2.5% and 3.75% - administered daily ... [Published Mar 09 2010 by News-Medical.Net]
First Reported Mar 08 2010 - Updated Mar 08 2010 - 1 Documents

Warning sign for potential anti-cancer approach

One treatment being investigated as an adjuvant for anticancer immunotherapies is the use of molecules that trigger the proteins TLR7 and TLR8. For example, the TLR7 stimulant imiquimod is used for the treatment of skin cancer and metastatic melanoma. ... [Published Mar 08 2010 by Genetic Engineering News]
First Reported Mar 03 2010 - Updated Mar 03 2010 - 1 Documents

Innovations in scar prevention, management continue to expand

Key Points Careful planning, technique allow for less scarringSome procedures for scars, such as dermabrasion, best performed during remodeling phaseSilicone gel sheeting shown to effectively treat hypertrophic scars, expert saysDr. SpencerSt. Petersburg, ... [Published Mar 03 2010 by Modern Medicine]
First Reported Mar 01 2010 - Updated Mar 01 2010 - 1 Documents

Generic Imiquimod Cream Approved

The FDA has approved E. Fougera & Co.’s imiquimod 5% cream, the generic equivalent of Aldara by Graceway Pharmaceuticals. The generic product is AB-rated and substitutable for all indications, which include the treatment of external genital and perianal ... [Published Mar 01 2010 by Facts & Comparisons]
First Reported Feb 27 2010 - Updated Feb 27 2010 - 1 Documents

Actinic Keratosis

Actinic keratosis is a premalignant neoplasm of the epidermis characterized by abnormal proliferation of keratinocytes that have the potential to progress to squamous cell carcinoma of the skin.Actinic keratosis lesions are the result of chronic sun exposure ... [Published Feb 27 2010 by Advance for Healthy Aging]
First Reported Feb 26 2010 - Updated Feb 27 2010 - 3 Documents

2/26/10 - Fougera wins FDA approval for generic Aldara

(Datamonitor via COMTEX) E Fougera & Co, a division of Nycomed US, has received first generic approval from the FDA for imiquimod cream 5%.Fougera's imiquimod cream 5% is rated AB, generically equivalent to Aldara by Graceway Pharmaceuticals and substitutable ... [Published Feb 27 2010 by Pharmacy Choice]
First Reported Feb 26 2010 - Updated Feb 26 2010 - 1 Documents

E. Fougera receives first generic approval for Imiquimod Cream 5%

E. Fougera & Co., a leading specialty pharmaceutical manufacturer, today announced it has received first generic approval from the FDA for Imiquimod Cream 5% (Rx). Fougera's Imiquimod Cream 5% is rated AB, generically equivalent to Aldara® by Graceway ... [Published Feb 26 2010 by News-Medical.Net]
First Reported Jan 07 2010 - Updated Jan 07 2010 - 1 Documents

Graceway Pharma gets Health Canada nod for Zyclara cream to treat precancerous skin condition

Graceway Pharmaceuticals, LLC announced that Health Canada has approved Zyclara (imiquimod) cream 3.75 per cent for the treatment of multiple actinic keratosis (AK) of the face or balding scalp in adults with normal immune systems. Actinic Keratosis is ... [Published Jan 07 2010 by PharmaBiz]

Quotes

...cycles," said C William Hanke, M D , lead investigator of the 3-week study and Visiting Professor, , University of Iowa-Carver College of Medicine. "Further studies will evaluate imiquimod for sustained clearance of AKs, beyond the 8-week follow-up assessed in these studies."
...Charles Lynde, dermatologist and assistant clinical professor at the University of Toronto. "This helps increase compliance which ultimately helps achieve long term medical clearance of lesions and desired cosmetic outcomes."

More Content

All (17) | News (17) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0)
sort by: Date | Relevance
Graceway Announces Journal Of The American Acad... [MediLexicon - Mar 10 2010]
New and Generic Drug Approvals [U.S. Food and Drug Administration - Mar 09 2010]
Phase III study demonstrates superiority of imi... [News-Medical.Net - Mar 09 2010]
JAAD publishes Phase III data evaluating safety... [News-Medical.Net - Mar 09 2010]
Warning sign for potential anti-cancer approach [Genetic Engineering News - Mar 08 2010]
JCI online early table of contents: March 8, 2010 [Genetic Engineering News - Mar 08 2010]
Innovations in scar prevention, management cont... [Modern Medicine - Mar 03 2010]
Generic Imiquimod Cream Approved [Facts & Comparisons - Mar 01 2010]
Actinic Keratosis [Advance for Healthy Aging - Feb 27 2010]
2/26/10 - Fougera wins FDA approval for generic... [Pharmacy Choice - Feb 27 2010]
Fougera wins FDA approval for generic Aldara [Pharmacy Choice - Feb 27 2010]
Fougera receives FDA approval for generic Aldara [Drug Store News - Feb 26 2010]
E. Fougera receives first generic approval for ... [News-Medical.Net - Feb 26 2010]
Potential Signals of Serious Risks/New Safety I... [U.S. Food and Drug Administration - Feb 19 2010]
Graceway Extends Partnership with NASCAR Campin... [Forbes.com - Feb 12 2010]
Graceway Pharma gets Health Canada nod for Zycl... [PharmaBiz - Jan 07 2010]
Graceway Presents Results For Phase III Actinic... [Pharmaceutical Business Review - Aug 04 2009]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
How To Use
Silobreaker
RSS
API
Widgets
Advertise With Us
Advertise


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2009 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.